MENU
Articles by #hashtag

Pharmaceutical industry

8 hits
Pharmaceutical research

Hungarian Pharma Firm Launches New Product

D&T
Aug 21, 2019

Hungarian pharmaceutical company Gedeon Richter Plc. said that it launched a biosimilar teriparatide drug called Terrosa® in Europe. The product is approved in adults for the same indications as Eli Lilly’s Forsteo® and is used for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. Terrosa is also used […]

Richter's Antipsychotic Drug to Be Sold in the Middle East and North Africa

D&T
Jul 25, 2019

Hungarian pharma firm Gedeon Richter has signed an exclusive license agreement with Hikma Pharmaceuticals Plc. to sell Richter's anti-psychotic drug ‘cariprazine’ in some Middle Eastern and North African (MENA) markets. Under the terms of the agreement, Richter will be responsible for product supply and Hikma will proceed with the registration and commercialization of the product […]

The new Richter Gedeon lab in Debrecen | Zsolt Czeglédi /MTI

Pharma research lab opened in Debrecen

D&T
Mar 29, 2018

A new molecular biology laboratory of the Hungarian pharmaceutical company Richter Gedeon was inaugurated in Debrecen, E Hungary. The new lab serves the company's objectives of appearing on new markets internationally.

Xellia Pharmaceuticals testing center opens in Budapest | HIPA

Xellia Pharmaceuticals testing center opens

D&T
Aug 23, 2017

The latest development by the Danish pharmaceutical company Xellia Pharmaceuticals has been completed at its Kõbánya site in Budapest. The laboratory constructed as part of a development of EUR 11 million will operate as a testing centre for active ingredients.

Researcher in Richter's laboratory | source: richter.hu

Hungarian drug greenlighted for the EU

D&T
Jul 19, 2017

The Hungarian pharmaceutical company Gedeon Richter Plc. has announced that the European Commission has granted marketing authorization to Reagila (cariprazine) a novel antipsychotic for the treatment of schizophrenia in adult patients.

Christopher Hunley

GSK to launch new development in Hungary

D&T
Mar 16, 2017

GlaxoSmithKline (GSK) is launching a development worth EUR 57 million in its Gödöllõ plant. Upon completion of the investment, the plant will have expanded activity, producing diphtheria and tetanus vaccine (DT and TT) components for new areas of use.

Research at Richter Gedeon Plc. | source: richter.hu

A key Richter drug to be used in Western Europe

D&T
Aug 10, 2016

Hungary’s leading pharmaceutical company, Gedeon Richter Plc., has signed an exclusive license agreement with Recordati to commercialize cariprazine, a novel atypical antipsychotic in Western Europe and in Algeria, Tunisia and Turkey.

Research at Gedeon Richter | richter.hu

Hungarian company buys out Chinese partner

D&T
Jan 23, 2016

Hungary’s largest drugs producer, Gedeon Richter Plc., has announced that it bought out its Chinese partner, obtaining its outstanding 50% stake, further strengthening its presence in China, the Hungarian financial website portfolio.hu reports.

© Copyright 2019 Duax Kft. –  All rights reserved.
searchalign-justifytwitterfacebookfeedinstagrammoon-osun